Showing results (891-900 of 31,337) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activationYongying Jiang, Jiye Han, Chengzhi Yu, et al.Journal of Medicinal Chemistry|July 11, 2006
(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing propertiesRyo Tatsumi, Masakazu Fujio, Shin-ichi Takanashi, et al.Journal of Medicinal Chemistry|July 11, 2006
Semisynthetic maytansine analogues for the targeted treatment of cancerWayne C Widdison, Sharon D Wilhelm, Emily E Cavanagh, et al.Journal of Medicinal Chemistry|July 11, 2006
Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and pharmacological characterization of gamma-aminobutyric acid (GABA) related compoundsMarco L Lolli, Suzanne L Hansen, Barbara Rolando, et al.Journal of Medicinal Chemistry|May 28, 2020
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical SpeciesWu Yang, Yufeng Wang, Amy Lai, et al.Journal of Medicinal Chemistry|May 29, 2020
Fragment-Based Discovery of Pyrazolopyridones as JAK1 Inhibitors with Excellent Subtype SelectivityBettina Borreschmidt Hansen, Tue Heesgaard Jepsen, Mogens Larsen, et al.Journal of Medicinal Chemistry|June 9, 2020
Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial DiseasesXiawei Dang, Lihong Zhang, Antonietta Franco, et al.Journal of Medicinal Chemistry|June 11, 2020
Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of ActionAlessandro Bonardi, Alessio Nocentini, Silvia Bua, et al.Journal of Medicinal Chemistry|May 7, 2021
Breaking Oncogene Addiction: Getting RTK/RAS-Mutated Cancers off the SOSErin Sheffels, Robert L KortumJournal of Medicinal Chemistry|May 7, 2021
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity RelationshipsVladimir Burmistrov, Rahul Saxena, Dmitry Pitushkin, et al.Pageof 3,134